VIRUS - VACCINE RESEARCH - AP 4-9-2020 2.jpeg
- Updated
In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a pharmacy technologist using a biosafety level 2 hood prepares a COVID-19 coronavirus vaccine candidate for testing in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)
As featured on
The treatment is monoclonal antibody therapy, and the antibodies come from people who have recovered from the novel coronavirus. Researchers then take the blood, select the most potent antibodies, and make them into a drug.
Most Popular
Articles
- 3 people killed, including 1-year-old, in wrong-way crash on I-65 in southern Indiana
- 2 women shot and killed at Family Scholar House near University of Louisville campus
- Loved ones clean gravesites at Louisville Cemetery as owner plans to stop new burials
- 16-year-old boy shot in Middletown early Saturday morning, Louisville police say
- New Kentucky State Fair record set in annual giant pumpkin contest
- Bald eagle hit by vehicle in Washington County dies despite rescue efforts
- Man dies after being hit by train in Louisville's Park Hill neighborhood, police say
- Louisville man arrested after allegedly assaulting woman pregnant with twins
- LMPD asks for help identifying man believed to be victim of crime
- Louisville basketball dismisses former G League guard London Johnson